Arrhythmias and COVID-19: a review

P Dherange, J Lang, P Qian, B Oberfeld… - Clinical …, 2020 - jacc.org
Current understanding of the impact of coronavirus disease-2019 (COVID-19) on
arrhythmias continues to evolve as new data emerge. Cardiac arrhythmias are more …

European Society of Cardiology guidance for the diagnosis and management of cardiovascular disease during the COVID-19 pandemic: part 1—epidemiology …

Task Force for The Management of COVID … - Cardiovascular …, 2022 - academic.oup.com
Aims Since its emergence in early 2020, the novel severe acute respiratory syndrome
coronavirus 2 causing coronavirus disease 2019 (COVID-19) has reached pandemic levels …

Artificial intelligence–enabled assessment of the heart rate corrected QT interval using a mobile electrocardiogram device

JR Giudicessi, M Schram, JM Bos, CD Galloway… - Circulation, 2021 - Am Heart Assoc
Background: Heart rate–corrected QT interval (QTc) prolongation, whether secondary to
drugs, genetics including congenital long QT syndrome, and/or systemic diseases including …

Cardiac arrhythmias in patients with COVID‐19

Y Wang, Z Wang, G Tse, L Zhang, EY Wan… - Journal of …, 2020 - Wiley Online Library
The emergence of coronavirus disease 2019 (COVID‐19), caused by the severe acute
respiratory syndrome coronavirus 2 (SARS‐CoV‐2) has become a major global public …

Guidance on minimizing risk of drug-induced ventricular arrhythmia during treatment of COVID-19: a statement from the Canadian Heart Rhythm Society

JL Sapp, W Alqarawi, CJ MacIntyre, R Tadros… - Canadian Journal of …, 2020 - Elsevier
The COVID-19 pandemic has led to efforts at rapid investigation and application of drugs
which may improve prognosis but for which safety and efficacy are not yet established. This …

Smartwatch electrocardiogram and artificial intelligence for assessing cardiac-rhythm safety of drug therapy in the COVID-19 pandemic. The QT-logs study

B Maille, M Wilkin, M Million, N Rességuier… - International journal of …, 2021 - Elsevier
Background QTc interval monitoring, for the prevention of drug-induced arrhythmias is
necessary, especially in the context of coronavirus disease 2019 (COVID-19). For the …

QT interval prolongation under hydroxychloroquine/azithromycin association for inpatients with SARS‐CoV‐2 lower respiratory tract infection

SS Bun, P Taghji, J Courjon, F Squara… - Clinical …, 2020 - Wiley Online Library
Association between Hydroxychloroquine (HCQ) and Azithromycin (AZT) is under
evaluation for patients with lower respiratory tract infection (LRTI) caused by the Severe …

[HTML][HTML] Implementation of a fully remote randomized clinical trial with cardiac monitoring

JJ Mayfield, NA Chatterjee, PA Noseworthy… - Communications …, 2021 - nature.com
Background The coronavirus disease 2019 (COVID-19) pandemic has challenged
researchers performing clinical trials to develop innovative approaches to mitigate infectious …

[HTML][HTML] Cardiovascular implications of COVID-19 infections

AN Thakkar, I Tea, MH Al-Mallah - … DeBakey cardiovascular journal, 2020 - ncbi.nlm.nih.gov
Since early 2020, the world has been facing a pandemic caused by the novel coronavirus
SARS-CoV-2. Although this positive single-stranded RNA virus primarily causes pulmonary …

[HTML][HTML] Clinical validation of automated corrected QT-interval measurements from a single lead electrocardiogram using a novel smartwatch

D Mannhart, E Hennings, M Lischer… - Frontiers in …, 2022 - frontiersin.org
Introduction: The Withings Scanwatch (Withings SA, Issy les Moulineaux, France) offers
automated analysis of the QTc. We aimed to compare automated QTc-measurements using …